• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过与血浆心房钠尿肽(ANP)和脑钠肽(BNP)比较评估最适用于123I-间碘苄胍(MIBG)心肌摄取定量的背景减除方法]

[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].

作者信息

Yahara Y, Nomura Y, Okamoto S, Saitou K, Okamoto R, Makino K, Aoki S, Takeda K

机构信息

Department of Radiology, Mie University School of Medicine.

出版信息

Kaku Igaku. 2000 May;37(3):217-25.

PMID:10860352
Abstract

BACKGROUND

Quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake is widely accepted as a useful tool for estimating the severity of congestive heart failure. However, most reliable method has not been determined yet because of the difficulty of background (BG) subtraction. In this study, the most appropriate BG subtraction method was evaluated as compared with plasma atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), norepinephrine (NEP) and left ventricular ejection fraction (LVEF).

METHODS

Twenty-one patients with chronic heart failure were examined. After bolus injection of 123I-MIBG (111 MBq), dynamic anterior chest images were collected every second for 2 minutes. Planar anterior chest images were obtained 15 minutes (early image) and 4 hours later (delayed image) respectively. The parameters for quantification of 123I-MIBG myocardial uptake used in this study were heart to mediastinum ratio (H/M), myocardial washout rate and uptake ratio. Background was calculated using the region of interest (ROI) placed over a part of upper mediastinum, whole upper mediastinum, right lung and pericardial space respectively. The values of these parameters were calculated with and without BG subtraction and compared with plasma ANP, BNP and others.

RESULTS

H/M did not correlate with ANP or BNP. Myocardial washout rate without BG subtraction showed significant correlation with ANP (p < 0.01) and BNP (p < 0.05). After BG subtraction employing ROI placed over the part of upper mediastinum and whole upper mediastinum, myocardial washout rate showed better correlation with BNP (p < 0.01). Myocardial uptake ratio did not showed any correlation with ANP or BNP without BG subtraction. However, myocardial uptake ratio showed significant correlation with BNP (p < 0.05) after subtraction of upper mediastinal BG. BG subtraction using ROI over right lung or pericardial area revealed poor results in both myocardial washout rate- and uptake ratio.

CONCLUSION

BG subtraction using ROI over the upper mediastinum is likely to be suitable for quantitative analysis of 123I-MIBG myocardial scintigram.

摘要

背景

123I-间碘苄胍(MIBG)心肌摄取量的定量分析作为评估充血性心力衰竭严重程度的一种有用工具已被广泛接受。然而,由于背景(BG)扣除困难,尚未确定最可靠的方法。在本研究中,将最适宜的BG扣除方法与血浆心房利钠肽(ANP)、脑利钠肽(BNP)、去甲肾上腺素(NEP)和左心室射血分数(LVEF)进行比较来评估。

方法

对21例慢性心力衰竭患者进行检查。静脉推注123I-MIBG(111 MBq)后,每秒采集一次动态前胸图像,共采集2分钟。分别于15分钟(早期图像)和4小时后(延迟图像)获取平面前胸图像。本研究中用于定量分析123I-MIBG心肌摄取的参数为心纵隔比(H/M)、心肌洗脱率和摄取率。背景分别使用置于上纵隔部分、整个上纵隔、右肺和心包腔的感兴趣区(ROI)进行计算。计算有和没有BG扣除时这些参数的值,并与血浆ANP、BNP等进行比较。

结果

H/M与ANP或BNP无相关性。未进行BG扣除时的心肌洗脱率与ANP(p < 0.01)和BNP(p < 0.05)显著相关。采用置于上纵隔部分和整个上纵隔的ROI进行BG扣除后,心肌洗脱率与BNP的相关性更好(p < 0.01)。未进行BG扣除时,心肌摄取率与ANP或BNP均无相关性。然而,扣除上纵隔BG后,心肌摄取率与BNP显著相关(p < 0.05)。使用右肺或心包区域的ROI进行BG扣除,在心肌洗脱率和摄取率方面均显示效果不佳。

结论

使用上纵隔的ROI进行BG扣除可能适用于123I-MIBG心肌闪烁显像的定量分析。

相似文献

1
[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].[通过与血浆心房钠尿肽(ANP)和脑钠肽(BNP)比较评估最适用于123I-间碘苄胍(MIBG)心肌摄取定量的背景减除方法]
Kaku Igaku. 2000 May;37(3):217-25.
2
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.血管紧张素II受体拮抗剂对慢性心力衰竭患者[(123)I]间碘苄胍心肌显像结果及神经体液因子的影响
Heart Vessels. 2002 Dec;17(2):47-52. doi: 10.1007/s003800200042.
3
[Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].[123I-间碘苄胍心肌显像的定量分析:评估其在充血性心力衰竭患者中的应用价值]
Kaku Igaku. 1994 Apr;31(4):347-58.
4
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.心肌碘-123 间碘苄胍显像与心力衰竭中的心脏事件。前瞻性 ADMIRE-HF(AdreView 心肌成像用于心力衰竭风险评估)研究的结果。
J Am Coll Cardiol. 2010 May 18;55(20):2212-21. doi: 10.1016/j.jacc.2010.01.014. Epub 2010 Feb 25.
5
Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.心肌交感神经活动受损可能反映肥厚型心肌病中心肌损伤或功能障碍的进展。
J Nucl Cardiol. 2002 Jul-Aug;9(4):407-12. doi: 10.1067/mnc.2002.122765.
6
A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.多中心队列研究的荟萃分析:(123)I-间碘苄胍成像用于评估心力衰竭的长期预后中的交感神经支配。
JACC Cardiovasc Imaging. 2013 Jul;6(7):772-84. doi: 10.1016/j.jcmg.2013.02.007.
7
[Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].[心力衰竭患者的长期预后评估:碘-123间碘苄胍心脏显像是否有用?]
J Cardiol. 1998 Jun;31(6):343-9.
8
Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause.碘-123间碘苄胍显像反映了充血性心力衰竭时强烈的心肌肾上腺素能神经活动,与潜在病因无关。
J Am Coll Cardiol. 1995 Dec;26(7):1594-9. doi: 10.1016/0735-1097(95)00374-6.
9
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Nucl Med Commun. 2002 Aug;23(8):795-801. doi: 10.1097/00006231-200208000-00014.
10
[Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].[123I-间碘苄胍心肌闪烁显像在心脏瓣膜病患者中的临床评估]
J Cardiol. 1995 May;25(5):247-53.